Journal of Peking University(Health Sciences) ›› 2017, Vol. 49 ›› Issue (6): 954-960. doi: 10.3969/j.issn.1671-167X.2017.06.004

• Article • Previous Articles     Next Articles

Effect of high glucose-based peritoneal dialysis fluids on NLRP3-IL-1β in human peritoneal mesothelial cells#br#

LI Xiang-you, WU Jun△, LUO Dan, CHEN Wan-xian, ZHU Ge-li, ZHANG Yan-xia, BI Zhi-min, FENG Bao-hong   

  1. (Department of Nephrology,Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan 430068, China)
  • Online:2017-12-18 Published:2017-12-18
  • Contact: WU Jun E-mail: wujun2@mail3.sysu.edu.cn
  • Supported by:
    Supported by National Natural Science Foundation of China (81200555), Natural Science Foundation of Hubei Province (2016CFB590), and Project of Health and Fa-mily Planning Commission of Wuhan Municipality (WX16B09)

Abstract: Objective: To explore the effect of high glucose-based peritoneal dialysis fluids on NLRP3-IL-1β in human peritoneal mesothelial cells. Methods: HMrSV5 cells (SV40 immortalized human peritoneal mesothelial cell line) were grown in type Ⅰ collagen-coated dishes in DMEM/F12 containing 10% fetal calf serum (FCS). All experiments on HMrSV5 cells were performed between passages 5 and 10-The cells were divided into 7 groups: control, 1-5% dextrose, 2-5% dextrose, 425% dextrose, rotenone, thenoyltrifluoroacetone (TTFA), and antimycin A-Immunoblotting was used to evaluate the expression of IL-1β-Small interfering RNA (siRNA) targeting NLRP3 was used to downregulate the expression of NLRP3 and Western blot was used to evaluate the expression of IL-1β in human peritoneal mesothelial cells exposed to 4-25% dextrose- In the meanwhile, resveratrol (RSV) was used to induce autophagy, 3-methyladenine (3-MA) and siRNA against Beclin 1 or ATG5 were used to block auto-phagy, flow cytometric was used to analyze the respiring (mitotracker deep red), total (mitotracker green) and reactive oxygen species (ROS)generating mitochondria (mitoSOX); Western blot was used to evaluate the expression of IL-1β- Results: The IL-1β relative expressions were 0, 0-175±0-082, 0-418±0-163, 2-357±0-288, 2-642±0-358, 3-271±0-462, and 0-123±0-091, indicating that the cells exposed to high glucose-based peritoneal dialysis fluids and cells treated with mitochondria respiratory chain key enzyme complex Ⅰ, and complex Ⅲ inhibitors increased the IL-1β expression- And we found that NLRP3 knock-down significantly blocked the upregulation of IL-1β- In addition, the fluorescence intensity of total mitochondria and ROS-generating mitochondria in the following groups: control, negative control, RSV, 3-MA, ATG5 siRNA, Beclin1 siRNA were 1-76±0-42, 1-83±0-55, 1-85±0-62, 7-36±0-92, 5-35±0-77, 5-06±0-62 and 821-68±95-12, 868-15±102-82, 723-39±92-56, 1 660-08±113-65, 1 433-01±107-24, 1 562-36±112-88 respectively- The increased concentrations of mitochondrial ROS and IL-1β upregulation were confirmed in the inhibition but not the induction of auto-phagy-We also found that downregulation of ATG5 and Beclin1 sensitized cells for the release of IL-1β induced by MSU (monosodium urate) or nigericin which was the NLRP3 inflammasome activator- RSV treatment attentuated this effect- Conclusion: Long-term application of high glucose-based peritoneal dialysis fluids can trigger the consistent activation of NLRP3-IL-1β in peritoneal mesothelial cells-Timely initiation of autophagy may block the NLRP3-IL-1β activation and provide a basis for the further development of a potential therapeutic strategy for delay of chronic inflammation and peritoneal fibrosis associated with peritoneal dialysis.

Key words: High glucose-based peritoneal dialysis fluids, Human peritoneal mesothelial cells, NLRP3, IL-1β

CLC Number: 

  • R692
[1] Handong DING, Qin WANG, Guiyi LIAO, Zongyao HAO. Diagnosis and treatment of gastrointestinal bleeding after kidney transplantation [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 902-907.
[2] Silu CHEN, Haiju WANG, Yucai WU, Zhihua LI, Yanbo HUANG, Yuhui HE, Yangyang XU, Xuesong LI, Hua GUAN. Etiological analysis of hydronephrosis in adults: A single-center cross-sectional study [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 913-918.
[3] Mingrui WANG, Qi WANG, Hao HU, Jinhui LAI, Xinwei TANG, Chunyan WAN, Kexin XU, Tao XU. Efficacy of coated metal ureteral stent in the treatment of pelvic lipomatosis induced hydronephrosis [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 919-922.
[4] Shengqi ZHENG,Tianchi HUA,Guicao YIN,Wei ZHANG,Ye YAO,Yifan LI. Association between the triglyceride-glucose index and the incidence of nephrolithiasis in male individuals [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 610-616.
[5] Mingrui WANG,Jun LIU,Liulin XIONG,Luping YU,Hao HU,Kexin XU,Tao XU. Efficacy and safety of mini-track, mini-nephroscopy and mini-ultrasonic probe percutaneous nephrolithotomy for the treatment of 1.5-2.5 cm kidney stones [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 605-609.
[6] Ming-rui WANG,Jia-xiang JI,Jin-hui LAI,Xin-wei TANG,Hao-pu HU,Qi WANG,Ke-xin XU,Tao XU,Hao HU. Choice of medical treatment for renal colic: A survey of Chinese urologists [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 871-875.
[7] Wen-han BAO,Wen TANG. Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 124-132.
[8] Zi WANG,Jun-jun ZHANG,Li ZUO,Yue WANG,Wen-ge LI,Hong CHENG,Guang-yan CAI,Hua-ying PEI,Li-hua WANG,Xu-jie ZHOU,Su-fang SHI,Li-jun LIU,Ji-cheng LV,Hong ZHANG. Efficacy of plasma exchange in severe crescentic IgA nephropathy: A multicentered, cohort study [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1038-1046.
[9] Lin MA,Jing-yi WU,Shuang-cheng LI,Peng-fei LI,Lu-xia ZHANG. Effect of modification of antihypertensive medications on the association of nitrogen dioxide long-term exposure and chronic kidney disease [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1047-1055.
[10] Ling-yi XU,Miao HUI,Shu-hong ZHU,Zhao YANG,Meng-rui LI,Hong-yu YANG,Xi-zi ZHENG,Ji-cheng LV,Li YANG. Chronic kidney disease in community: Current state for screening and management [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1056-封三.
[11] DAI Xiang,ZUO Mei-ni,ZHANG Xiao-peng,HU Hao,XU Tao. Comparison of long-term outcomes in different managements of diverticular neck in percutaneous nephrolithotomy for diverticular calculi [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 704-709.
[12] QIU Min,WANG Lu,DENG Shao-hui,TA Peng-fei,GUO Wei,LU Jian,LIU Cheng,MA Lu-lin. Primary application of Gerota’s fascia suspension device in retroperitoneal laparoscopic partial nephrectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 789-792.
[13] ZHOU Guang-ping,ZHOU Qian-yun,ZHU Ji-hong. A case report of TAFRO syndrome [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 814-817.
[14] Wen SUN,Ang LI,Jun-qing ZHANG,Zhen-fang YUAN. Low-dose adefovir-induced Fanconi syndrome and hypophosphatemic osteomalacia: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 975-979.
[15] Ming-rui WANG,Qi WANG,Hao HU,Jin-hui LAI,Yong-xin HE,Jie XIONG,Xian-hui LIU,Shi-jun LIU,Ke-xin XU,Tao XU. Long-term analysis of safety and efficacy of standard percutaneous nephrolithotomy in patients with solitary kidneys [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 663-666.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!